Showing results (221-230 of 234) with videos related to
Sort By:
Pageof 24
Molecular Cancer Therapeutics|September 4, 2008
Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancerYoganand Balagurunathan, David L Morse, Galen Hostetter, et al.Journal of Medicinal Chemistry|February 13, 2008
A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonistsTakashi Yamamoto, Padma Nair, Josef Vagner, et al.Molecules (Basel, Switzerland)|January 11, 2025
Design, Structure-Activity Relationships, and Computational Modeling Studies of a Series of α-Helix Biased, Ultra-Short Glucagon-like Peptide-1 Receptor AgonistsJonathon R Sawyer, Joseph A Audie, Jon Swanson, et al.Journal of the American Chemical Society|April 19, 2014
Discovery of amphipathic dynorphin A analogues to inhibit the neuroexcitatory effects of dynorphin A through bradykinin receptors in the spinal cordYeon Sun Lee, Dhanasekaran Muthu, Sara M Hall, et al.Molecular Pharmaceutics|December 30, 2015
Tumor Targeting and Pharmacokinetics of a Near-Infrared Fluorescent-Labeled δ-Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5Amanda Shanks Huynh, Veronica Estrella, Valerie E Stark, et al.Journal of the American Chemical Society|April 14, 2005
Glycopeptides related to beta-endorphin adopt helical amphipathic conformations in the presence of lipid bilayersMuthu Dhanasekaran, Michael M Palian, Isabel Alves, et al.Journal of Medicinal Chemistry|July 19, 2013
Development and in vivo quantitative magnetic resonance imaging of polymer micelles targeted to the melanocortin 1 receptorNatalie M Barkey, Christian Preihs, Heather H Cornnell, et al.The Journal of Pharmacology and Experimental Therapeutics|May 29, 2004
Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptidesNura O Elmagbari, Richard D Egleton, Michael M Palian, et al.Brain Research|May 10, 2011
Novel peptide ligands with dual acting pharmacophores designed for the pathophysiology of neuropathic painKatherine E Hanlon, Dave S Herman, Richard S Agnes, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 31, 2016
Characterization of TCP-1 probes for molecular imaging of colon cancerZhonglin Liu, Brian D Gray, Christy Barber, et al.Pageof 24